title: Signals from CD28 induce stable epigenetic modification of the IL-2 promoter.
abstract: CD28 costimulation controls multiple aspects of T cell function, including the expression of proinflammatory cytokine genes. One of these genes encodes IL-2, a growth factor that influences T cell proliferation, survival, and differentiation. Antigenic signaling in the absence of CD28 costimulation leads to anergy, a mechanism of tolerance that renders CD4+ T cells unable to produce IL-2. The molecular mechanisms by which CD28 costimulatory signals induce gene expression are not fully understood. In eukaryotic cells, the expression of many genes is influenced by their physical structure at the level of DNA methylation and local chromatin remodeling. To address whether these epigenetic mechanisms are operative during CD28-dependent gene expression in CD4+ T cells, we compared cytosine methylation and chromatin structure at the IL-2 locus in fully activated CD4+ effector T cells and CD4+ T cells rendered anergic by TCR ligation in the absence of CD28 costimulation. Costimulation through CD28 led to marked, stable histone acetylation and loss of cytosine methylation at the IL-2 promoter/enhancer. This was accompanied by extensive remodeling of the chromatin in this region to a structure highly accessible to DNA binding proteins. Conversely, TCR activation in the absence of CD28 costimulation was not sufficient to promote histone acetylation or cytosine demethylation, and the IL-2 promoter/enhancer in anergic cells remained completely inaccessible. These data suggest that CD28 may function through epigenetic mechanisms to promote CD4+ T cell responses.
authors.affiliation: Joseph Stokes, Jr., Research Institute, The Children's Hospital of Philadelphia, PA 19104, USA.
authors.forename: Rajan M
authors.initials: RM
authors.lastname: Thomas
authors.forename: Ling
authors.initials: L
authors.lastname: Gao
authors.forename: Andrew D
authors.initials: AD
authors.lastname: Wells
mesh_terms: D000107:Acetylation; D000818:Animals; D001483:Base Sequence; D018106:CD28 Antigens / Q000378:metabolism*; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology / Q000378:metabolism; D002843:Chromatin / Q000235:genetics / Q000378:metabolism; D017635:Clonal Anergy; D018899:CpG Islands; D004247:DNA / Q000235:genetics; D019175:DNA Methylation; D004742:Enhancer Elements, Genetic; D044127:Epigenesis, Genetic; D015870:Gene Expression; D006657:Histones / Q000378:metabolism; D066298:In Vitro Techniques; D007376:Interleukin-2 / Q000235:genetics*; D008213:Lymphocyte Activation; D051379:Mice; D008810:Mice, Inbred C57BL; D011401:Promoter Regions, Genetic; D015398:Signal Transduction
chemical_list: D018106:CD28 Antigens; D002843:Chromatin; D006657:Histones; D007376:Interleukin-2; D004247:DNA